Hong Kong-listed Keymed Biosciences’ gastric cancer drug meets late-stage trial goals
July 28 (Reuters) – Hong Kong-listed Keymed Biosciences said on Tuesday a late-stage trial of sonesitatug ‌vedotin, a…
Browsing Tag